Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: Chang-Fen Huang, Ph.D., State University of New York at Stony Brook (SUNY-SB): Based on an investigation conducted by SUNY-SB dated December 18, 1997, ORI finds that Dr. Huang, former graduate student, Department of Biochemistry, SUNY-SB, engaged in scientific misconduct in the reporting and conducting of research supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). Specifically, ORI finds that: (1) Dr. Huang falsely mislabeled and relabeled six autoradiographs of Northern blots (ARG) that she had obtained from earlier unrelated experiments to make them appear to have come from several different and separate experiments. (2) For one of the sets noted in (1) above, Dr. Huang falsified and misrepresented portions of the ARG in panel B of figure 1, in C.F. Huang et al. \`\`Depolarization-transcription signals in skeletal muscle use calcium flux through L channels, but bypass the sarcoplasmic reticulum.\'\' Neuron 13:167-177, 1994. Figure 1B purported to show the effect of electrical activity on the expression of genes for subunits of the acetyl choline receptor, but actually used data derived from a separate and unrelated experiment showing the effect of phorbol esters on the expression of the myogenin gene that had been previously reported in an unrelated publication. The publication was retracted at Neuron 13(1):1294, 1998. (3) For one of the sets noted in (1) above, Dr. Huang falsified and misrepresented Figure VII/7, an aggregate ARG, on page 159 of her dissertation, \`\`Studies of the Signaling Pathway Coupling Membrane Depolarization and AchR Gene Inactivation in Chick Skeletal Muscle,\'\' December 1993. The figure reported the effect of a set of calcium- active agents on the sarcoplasmic reticulum that were different from those studied for the original ARG. Dr. Huang has accepted the ORI finding and has entered into a Voluntary Exclusion Agreement with ORI in which she has voluntarily agreed, for the three (3) year period beginning April 20, 1999: (1) To exclude herself from any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government as defined in 45 C.F.R. Part 76 (Debarment Regulations); and (2) to exclude herself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant.
